Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian H Unizony

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Rheumatic Diseases Clinics of North America|November 18, 2014
Challenging mimickers of primary systemic vasculitisEli M Miloslavsky, John H Stone, Sebastian H Unizony
The New England Journal of Medicine|February 26, 2015
Case Records of the Mass General Hospital. Case 7-2015: A 25-year-old man with oral ulcers, rash, and odynophagiaSebastian H Unizony, Nancy D Kim, Mai P Hoang
Arthritis Care & Research|April 6, 2020
Ustekinumab for the Treatment of Giant Cell ArteritisMark A Matza, Ana D Fernandes, John H Stone, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Treatment failure in giant cell arteritisSebastian H Unizony, Min Bao, Jian Han, et al.
Annals of the Rheumatic Diseases|October 17, 2025
Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatmentErnest H Choy, Sebastian H Unizony, Alvin F Wells, et al.
Ophthalmic Epidemiology|March 18, 2015
Accuracy of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) as a research tool for identification of patients with uveitis and scleritisEduardo Uchiyama, Sepideh Faez, Humzah Nasir, et al.
Clinical Rheumatology|April 4, 2014
Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literatureSepideh Faez, Ann-Marie Lobo, Sebastian H Unizony, et al.
Seminars in Arthritis and Rheumatism|March 30, 2021
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trialRobert Spiera, Sebastian H Unizony, Min Bao, et al.
RMD Open|April 6, 2023
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritisMark A Matza, Nicholas Dagincourt, Shalini V Mohan, et al.
Rheumatology and Therapy|December 26, 2021
The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA TrialNaomi J Patel, Xiaoqing Fu, Yuqing Zhang, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Rheumatic Diseases Clinics of North America|November 18, 2014
Challenging mimickers of primary systemic vasculitisEli M Miloslavsky, John H Stone, Sebastian H Unizony
The New England Journal of Medicine|February 26, 2015
Case Records of the Mass General Hospital. Case 7-2015: A 25-year-old man with oral ulcers, rash, and odynophagiaSebastian H Unizony, Nancy D Kim, Mai P Hoang
Arthritis Care & Research|April 6, 2020
Ustekinumab for the Treatment of Giant Cell ArteritisMark A Matza, Ana D Fernandes, John H Stone, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Treatment failure in giant cell arteritisSebastian H Unizony, Min Bao, Jian Han, et al.
Annals of the Rheumatic Diseases|October 17, 2025
Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatmentErnest H Choy, Sebastian H Unizony, Alvin F Wells, et al.
Ophthalmic Epidemiology|March 18, 2015
Accuracy of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) as a research tool for identification of patients with uveitis and scleritisEduardo Uchiyama, Sepideh Faez, Humzah Nasir, et al.
Clinical Rheumatology|April 4, 2014
Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literatureSepideh Faez, Ann-Marie Lobo, Sebastian H Unizony, et al.
Seminars in Arthritis and Rheumatism|March 30, 2021
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trialRobert Spiera, Sebastian H Unizony, Min Bao, et al.
RMD Open|April 6, 2023
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritisMark A Matza, Nicholas Dagincourt, Shalini V Mohan, et al.
Rheumatology and Therapy|December 26, 2021
The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA TrialNaomi J Patel, Xiaoqing Fu, Yuqing Zhang, et al.
Pageof 3